Cargando…

Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols

BACKGROUND: To facilitate mass distribution of azithromycin, trachoma control programmes use height instead of weight to determine dose for children 6 months to 15 years old. WHO has recommended azithromycin distribution to children 1–11 months old to reduce mortality in high mortality settings unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Huiyu, Arzika, Ahmed Mamane, Sie, Ali, Abdou, Amza, Maliki, Ramatou, Mankara, Alio Karamba, Outtara, Mamadou, Bountogo, Mamadou, Boudo, Valentin, Yago-Wienne, Fanny, Bamba, Issouf, Knirsch, Charles, Emerson, Paul, Hooper, PJ, Lebas, Elodie, Brogdon, Jessica, Nyatigo, Fanice, Oldenburg, Catherine E, Lietman, Thomas M, O'Brien, Kieran S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577904/
https://www.ncbi.nlm.nih.gov/pubmed/36253018
http://dx.doi.org/10.1136/bmjgh-2022-009801
_version_ 1784811859544637440
author Hu, Huiyu
Arzika, Ahmed Mamane
Sie, Ali
Abdou, Amza
Maliki, Ramatou
Mankara, Alio Karamba
Outtara, Mamadou
Bountogo, Mamadou
Boudo, Valentin
Yago-Wienne, Fanny
Bamba, Issouf
Knirsch, Charles
Emerson, Paul
Hooper, PJ
Lebas, Elodie
Brogdon, Jessica
Nyatigo, Fanice
Oldenburg, Catherine E
Lietman, Thomas M
O'Brien, Kieran S
author_facet Hu, Huiyu
Arzika, Ahmed Mamane
Sie, Ali
Abdou, Amza
Maliki, Ramatou
Mankara, Alio Karamba
Outtara, Mamadou
Bountogo, Mamadou
Boudo, Valentin
Yago-Wienne, Fanny
Bamba, Issouf
Knirsch, Charles
Emerson, Paul
Hooper, PJ
Lebas, Elodie
Brogdon, Jessica
Nyatigo, Fanice
Oldenburg, Catherine E
Lietman, Thomas M
O'Brien, Kieran S
author_sort Hu, Huiyu
collection PubMed
description BACKGROUND: To facilitate mass distribution of azithromycin, trachoma control programmes use height instead of weight to determine dose for children 6 months to 15 years old. WHO has recommended azithromycin distribution to children 1–11 months old to reduce mortality in high mortality settings under carefully monitored conditions. Weight was used to determine dose in children 1–5 months old in studies of azithromycin distribution for child survival, but a simplified approach using age or height for all aged 1–11 months old could increase programme efficiency in real-world settings. METHODS: This secondary analysis used data from two cluster randomised trials of azithromycin distribution for child mortality in Niger and Burkina Faso. An exhaustive search algorithm was developed to determine the optimal dose for different age groups, using tolerance limits of 10–20 mg/kg for children 1–2 months old and 15–30 mg/kg for children 3–11 months old. Height-based dosing was evaluated against the existing trachoma dosing pole and with a similar exhaustive search. RESULTS: The optimal two-tiered age-based approach suggested a dose of 80 mg (2 mL) for children 1–2 months old and 160 mg (4 mL) for children 3–11 months old. Under this schedule, 89%–93% of children would have received doses within tolerance limits in both study populations. Accuracy was 93%–94% with a three-tiered approach, which resulted in doses of 80 mg (2 mL), 120 mg (3 mL) and 160 mg (4 mL) for children 1–2, 3–4 and 5–11 months old, respectively. For children 1–5 months old, the existing height pole would result in 70% of doses within tolerance limits. The optimisation identified height-based dosing options with 95% accuracy, although this would require changes to the existing dosing pole as well as additional training to measure infants lying flat. CONCLUSIONS: Overall, an age-based approach with two age tiers resulted in high accuracy while considering both concerns about overdosing in this young population and simplicity of field operations.
format Online
Article
Text
id pubmed-9577904
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-95779042022-10-19 Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols Hu, Huiyu Arzika, Ahmed Mamane Sie, Ali Abdou, Amza Maliki, Ramatou Mankara, Alio Karamba Outtara, Mamadou Bountogo, Mamadou Boudo, Valentin Yago-Wienne, Fanny Bamba, Issouf Knirsch, Charles Emerson, Paul Hooper, PJ Lebas, Elodie Brogdon, Jessica Nyatigo, Fanice Oldenburg, Catherine E Lietman, Thomas M O'Brien, Kieran S BMJ Glob Health Original Research BACKGROUND: To facilitate mass distribution of azithromycin, trachoma control programmes use height instead of weight to determine dose for children 6 months to 15 years old. WHO has recommended azithromycin distribution to children 1–11 months old to reduce mortality in high mortality settings under carefully monitored conditions. Weight was used to determine dose in children 1–5 months old in studies of azithromycin distribution for child survival, but a simplified approach using age or height for all aged 1–11 months old could increase programme efficiency in real-world settings. METHODS: This secondary analysis used data from two cluster randomised trials of azithromycin distribution for child mortality in Niger and Burkina Faso. An exhaustive search algorithm was developed to determine the optimal dose for different age groups, using tolerance limits of 10–20 mg/kg for children 1–2 months old and 15–30 mg/kg for children 3–11 months old. Height-based dosing was evaluated against the existing trachoma dosing pole and with a similar exhaustive search. RESULTS: The optimal two-tiered age-based approach suggested a dose of 80 mg (2 mL) for children 1–2 months old and 160 mg (4 mL) for children 3–11 months old. Under this schedule, 89%–93% of children would have received doses within tolerance limits in both study populations. Accuracy was 93%–94% with a three-tiered approach, which resulted in doses of 80 mg (2 mL), 120 mg (3 mL) and 160 mg (4 mL) for children 1–2, 3–4 and 5–11 months old, respectively. For children 1–5 months old, the existing height pole would result in 70% of doses within tolerance limits. The optimisation identified height-based dosing options with 95% accuracy, although this would require changes to the existing dosing pole as well as additional training to measure infants lying flat. CONCLUSIONS: Overall, an age-based approach with two age tiers resulted in high accuracy while considering both concerns about overdosing in this young population and simplicity of field operations. BMJ Publishing Group 2022-10-17 /pmc/articles/PMC9577904/ /pubmed/36253018 http://dx.doi.org/10.1136/bmjgh-2022-009801 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Research
Hu, Huiyu
Arzika, Ahmed Mamane
Sie, Ali
Abdou, Amza
Maliki, Ramatou
Mankara, Alio Karamba
Outtara, Mamadou
Bountogo, Mamadou
Boudo, Valentin
Yago-Wienne, Fanny
Bamba, Issouf
Knirsch, Charles
Emerson, Paul
Hooper, PJ
Lebas, Elodie
Brogdon, Jessica
Nyatigo, Fanice
Oldenburg, Catherine E
Lietman, Thomas M
O'Brien, Kieran S
Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols
title Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols
title_full Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols
title_fullStr Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols
title_full_unstemmed Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols
title_short Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols
title_sort simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577904/
https://www.ncbi.nlm.nih.gov/pubmed/36253018
http://dx.doi.org/10.1136/bmjgh-2022-009801
work_keys_str_mv AT huhuiyu simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols
AT arzikaahmedmamane simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols
AT sieali simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols
AT abdouamza simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols
AT malikiramatou simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols
AT mankaraaliokaramba simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols
AT outtaramamadou simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols
AT bountogomamadou simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols
AT boudovalentin simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols
AT yagowiennefanny simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols
AT bambaissouf simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols
AT knirschcharles simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols
AT emersonpaul simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols
AT hooperpj simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols
AT lebaselodie simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols
AT brogdonjessica simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols
AT nyatigofanice simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols
AT oldenburgcatherinee simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols
AT lietmanthomasm simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols
AT obrienkierans simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols